C5AR2 and breast carcinoma: A recent study by Su et al. identified that CD10+ (MME+) GPR77+ (C5AR2+) CAFs promote breast cancer stem cell survival and resistance to chemotherapy through secretion of IL-6 and IL-8 (CXCL8) (Su et al., 2018).